Vardenafil hydrochloride prescription medication

Drugs with a possible risk for QT prolongation and TdP that should be used cautiously with vardenafil include degarelix. What side effects may I notice from receiving this medicine? Vardenafil hydrochloride prescription medication with a possible risk for QT prolongation and TdP that should be used cautiously and with close monitoring with metronidazole include vardenafil. Oral Route.

In addition, indinavir exposure may be reduced. In patients with moderate hepatic impairment Child-Pugh class Bdecrease initial dosage to 5 mg; maximum dosage is 10 mg once daily. The physiologic mechanism of erection of the penis involves release of nitric oxide NO in the corpus cavernosum vardenafil hydrochloride prescription medication sexual stimulation.

Severe Concomitant use of dronedarone and vardenafil is contraindicated. J Urol. Reduction in initial vardenafil dose required when given concomitantly with certain drugs that are potent or moderate CYP3A4 inhibitors.

Palmer BF. To facilitate attainment of a sexually functional erection in men vardenafil hydrochloride prescription medication ED impotence. Do not use the orally disintegrating tablets with concomitant moderate or potent CYP3A4 inhibitors e. Monitor patients for decreased pressor effect if these agents are administered concomitantly.

See also:

Alkyl nitrites

Vardenafil is a substrate of the hepatic isoenzyme CYP3A4; telaprevir inhibits vardenafil hydrochloride prescription medication isoenzyme. Drugs with a possible risk for QT prolongation and TdP that should be used cautiously and with close monitoring with atomoxetine include vardenafil. Caution should be exercised when administering sapropterin in combination with drugs that affect nitric oxide-mediated vasorelaxation such as phosphodiesterase inhibitors.

It can be expected that concomitant administration of CYP3A4 enzyme-inducers, such as nevirapine, will decrease plasma levels of vardenafil. Viracept nelfinavir tablets and oral powder prescribing information.

Use vardenafil at reduced doses of no more than 2. Carbetapentane; Chlorpheniramine; Phenylephrine:

Not studied in patients with hereditary degenerative retinal disorders, including those with retinitis pigmentosa. Vermeuler A.

ECG monitoring vardenafil hydrochloride prescription medication recommended; closely monitor the patient for QT interval prolongation. Moderate Etravirine is an inducer of CYP3A4; coadministration may result in decreased vardenafil concentrations. Drugs with a possible risk for QT prolongation and TdP that should be used cautiously with vardenafil include mefloquine.

From FDA website. Sotalol administration is associated with QT prolongation and torsades de pointes TdP. Schering-Plough, Kenilworth, NJ.

Major Concurrent use of vardenafil and moxifloxacin should be avoided due to an increased risk for QT prolongation and torsade de pointes TdP. Phenylephrine; Promethazine: